7-Deazapurines are known to possess broad antiviral activity, however the 2'-C-methylguanosine analogue displays poor cell permeation and limited phosphorylation, thus is not an efficient inhibitor of hepatitis C virus (HCV) replication. We previously reported the 6-O-methyl entity as a prodrug moiety to increase liphophilicity of guanine nucleosides and the ProTide approach applied to 2'-C-methyl-6-O-methylguanosine has lead to potent HCV inhibitors now in clinical trials. In this Letter, we report the synthesis and biological evaluation of 2'-C-methyl-6-O-methyl-7-deaza guanosine and ProTide derivatives. In contrast to prior studies, removal of the N-7 of the nucleobase entirely negates anti-HCV activity compared to the 2'-C-methyl-6-O-methylguanosine analogues. To understand better this significant loss of activity, enzymatic assays and molecular modeling were carried out and suggested 2'-C-methyl-6-O-methyl-7-deaza guanosine and related ProTides do not act as efficient prodrugs of the free nucleotide, in marked contrast to the case of the parent guanine analogue.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2012.12.004DOI Listing

Publication Analysis

Top Keywords

hepatitis virus
8
2'-c-methyl-6-o-methyl-7-deaza guanosine
8
synthesis evaluation
4
evaluation hepatitis
4
virus 7-deaza
4
7-deaza analogues
4
analogues 2'-c-methyl-6-o-methyl
4
2'-c-methyl-6-o-methyl guanosine
4
guanosine nucleoside
4
nucleoside l-alanine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!